Association of Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs With Cancer Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk
JAMA Netw Open 2024 Nov 04;7(11)e2446336, X Sendaydiego, LS Gold, M Dubreuil, JS Andrews, P Reid, DFL Liew, R Goulabchand, AG Singh, GC Hughes, M Pioro, JA Sparks, JG Jarvik, S Singh, JW Liew, N SinghFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.